» Articles » PMID: 8981929

An N-linked High-mannose Type Oligosaccharide, Expressed at the Major Outer Membrane Protein of Chlamydia Trachomatis, Mediates Attachment and Infectivity of the Microorganism to HeLa Cells

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1996 Dec 15
PMID 8981929
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The structure of the carbohydrate of the 40-kD major outer membrane component of Chlamydia trachomatis and its role in defining infectivity of the organism were investigated. The oligosaccharides were released from the glycoprotein by N-glycanase digestion, coupled to a 2-aminopyridyl residue, and subjected to two-dimensional sugar mapping technique. The major fractions consisted of "high-mannose type" oligosaccharides containing 8-9 mannose residues. Bi- and tri-antennary "complex type" oligosaccharides having terminal galactose were detected as minor components. These oligosaccharides were N-linked and contained no sialic acid. This structural profile is consistent with our previous characterization based on lectin-binding and glycosidase digestion. Functional specificity of identified chlamydial oligosaccharides was analyzed using glycopeptides fractionated from ovalbumin and structurally defined oligosaccharides from other sources. The glycopeptide fraction having high-mannose type oligosaccharide, as compared to those having complex or hybrid-type, showed a stronger inhibitory effect on attachment and infectivity of chlamydial organisms to HeLa cells. Among high-mannose type oligosaccharides, the strongest inhibition was observed with mannose 8 as compared with mannose 6, 7, or 9. These results indicate that a specific high-mannose type oligosaccharide linked to the major outer membrane protein of C. trachomatis mediates attachment and infectivity of the organism to HeLa cells.

Citing Articles

Advances in Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs.

Kiekens C, Morre S, Vanrompay D Microorganisms. 2024; 12(6).

PMID: 38930578 PMC: 11205628. DOI: 10.3390/microorganisms12061196.


Virulence Protein Pgp3 Is Insufficient To Mediate Plasmid-Dependent Infectivity of Chlamydia trachomatis.

Turman B, Alzhanov D, Nagarajan U, Darville T, OConnell C Infect Immun. 2023; 91(2):e0039222.

PMID: 36722979 PMC: 9933628. DOI: 10.1128/iai.00392-22.


Genomic and phenotypic comparison of strains possessing different virulence .

Kwack K, Jang E, Yang S, Lee J, Moon J Virulence. 2022; 13(1):1133-1145.

PMID: 35791444 PMC: 9262359. DOI: 10.1080/21505594.2022.2095718.


Cross-Serovar Protection during Experimental Lung Reinfection in Mice.

Lanfermann C, Kohn M, Laudeley R, Rheinheimer C, Klos A Vaccines (Basel). 2021; 9(8).

PMID: 34451996 PMC: 8402589. DOI: 10.3390/vaccines9080871.


Analysis of complement deposition and processing on Chlamydia trachomatis.

Lausen M, Thomsen M, Christiansen G, Karred N, Stensballe A, Bennike T Med Microbiol Immunol. 2020; 210(1):13-32.

PMID: 33206237 DOI: 10.1007/s00430-020-00695-x.


References
1.
Kuo C, Wang S, GRAYSTON J . Effect of polycations, polyanions and neuraminidase on the infectivity of trachoma-inclusin conjunctivitis and lymphogranuloma venereum organisms HeLa cells: sialic acid residues as possible receptors for trachoma-inclusion conjunction. Infect Immun. 1973; 8(1):74-9. PMC: 422812. DOI: 10.1128/iai.8.1.74-79.1973. View

2.
Kuo C, Grayston T . Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun. 1976; 13(4):1103-9. PMC: 420724. DOI: 10.1128/iai.13.4.1103-1109.1976. View

3.
Krusius T, Finne J, Rauvala H . The structural basis of the different affinities of two types of acidic N-glycosidic glycopeptides for concanavalin A--sepharose. FEBS Lett. 1976; 72(1):117-20. DOI: 10.1016/0014-5793(76)80911-8. View

4.
Finne J, Krusius T . Preparation and fractionation of glycopeptides. Methods Enzymol. 1982; 83:269-77. DOI: 10.1016/0076-6879(82)83020-6. View

5.
Caldwell H, Perry L . Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun. 1982; 38(2):745-54. PMC: 347801. DOI: 10.1128/iai.38.2.745-754.1982. View